| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/26/2007 | WO2007045407A2 Nutraceutical and pharmaceutical compositions containing choline as adiuvants for the prevention and treatment of retinopathies and glaucoma |
| 04/26/2007 | WO2007004060A3 Cytokine receptor modulators and uses thereof |
| 04/26/2007 | US20070093530 Substituted indolealkanoic acids |
| 04/26/2007 | US20070093513 Agent for repairing corneal perception |
| 04/26/2007 | US20070093507 Compositions comprising benzo (g) quinoline derivatives and prostaglandin derivatives |
| 04/26/2007 | US20070093416 Human beta-defensin secretion promoter |
| 04/26/2007 | CA2626181A1 Modulation of trpv expression levels |
| 04/26/2007 | CA2625848A1 Resorbable cornea button |
| 04/26/2007 | CA2625700A1 Prevention and treatment of drug-associated ocular side effects with a cyclosporin |
| 04/26/2007 | CA2624837A1 Method for treating primary and secondary forms of glaucoma |
| 04/25/2007 | EP1777519A1 Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma |
| 04/25/2007 | EP1777223A1 Indole derivatives useful as histamine H3 antagonists |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776962A1 Vaccine |
| 04/25/2007 | EP1776958A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/25/2007 | EP1776137A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
| 04/25/2007 | EP1776108A1 Enoximone formulations and their use in the treatment of pde-iii mediated diseases |
| 04/25/2007 | EP1776097A1 Methods of treating ophthalmic conditions |
| 04/25/2007 | EP1408950B1 Methods of treating cytokine mediated diseases |
| 04/25/2007 | EP1401449B1 Tetracyclic compounds as pde5-inhibitors |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP1210948B1 Therapeutc peptide for nervous diseases |
| 04/25/2007 | CN1953761A Methods using lycium barbarum extracts as neuroprotective agents for retinal ganglion cells degeneration |
| 04/25/2007 | CN1953740A Method of treating dry eye disorders and uveitis |
| 04/25/2007 | CN1951939A Novel pyrrole derivatives as pharmaceutical agents |
| 04/25/2007 | CN1951899A Aspirin-triggered lipid mediators |
| 04/25/2007 | CN1312181C Human monoclonal antibodies to FC Alpha receptor (CD89) |
| 04/25/2007 | CN1312153C Pyrrolopyrimidinone derivatives, process of preparation and use |
| 04/25/2007 | CN1312139C Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators |
| 04/25/2007 | CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 04/25/2007 | CN1311821C Nerve fiber regeneration accelerator |
| 04/24/2007 | US7208582 Polynucleotides codes for antibodies having amino acid sequences selected from complementary determining regions of variable peptides or single chain fragments, used as anticarcinogenic agents |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208512 Benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 04/24/2007 | US7208498 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 04/24/2007 | CA2403902C Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 04/24/2007 | CA2303763C Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| 04/24/2007 | CA2301711C Lipid-containing compositions and uses thereof |
| 04/24/2007 | CA2268741C Uses of keratinocyte growth factor-2 |
| 04/24/2007 | CA2182771C 11-(substituted phenyl)-estra-4,9-diene derivatives |
| 04/19/2007 | WO2007043629A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | WO2007043568A1 S1p3 receptor antagonist |
| 04/19/2007 | WO2007043457A1 Triarylcarboxylic acid derivative |
| 04/19/2007 | WO2006012779A8 Wikstroemia indeca extract their production and use in the production of anti-inflammatory pharmaceutical |
| 04/19/2007 | US20070088087 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 04/19/2007 | US20070088085 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 04/19/2007 | US20070088084 Malic acid addition salts of terbinafine |
| 04/19/2007 | US20070088059 Neuroprotectants; reduce side effect of neurotoxic agent; treatment of neuropathies resulting from chemotherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases, neurodegenerative diseases |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
| 04/19/2007 | US20070088003 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/19/2007 | US20070087969 Wound healing and treatment of fibrosis |
| 04/19/2007 | US20070086956 Method for accelerating the rate of mucociliary clearance |
| 04/19/2007 | CA2626011A1 S1p3 receptor antagonist |
| 04/19/2007 | CA2625206A1 Compstatin and analogs thereof for eye disorders |
| 04/19/2007 | CA2623563A1 Method of inhibiting angiogenesis by using ephrin b2 |
| 04/19/2007 | CA2621038A1 Triarylcarboxylic acid derivative |
| 04/18/2007 | EP1775286A1 Novel anandamide amidase inhibitors as analgesic agents |
| 04/18/2007 | EP1775283A1 3-aminobenamide compound and vanilloid receptor 1 (vr1) activity inhibitor |
| 04/18/2007 | EP1774977A2 Genetically engineered bleb vaccine |
| 04/18/2007 | EP1773350A2 Opthalmic compositions and methods for treating ophthalmic conditions |
| 04/18/2007 | EP1773335A2 Nanoparticle dispersion containing lactam compound |
| 04/18/2007 | EP1476438B1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/18/2007 | EP1476162B1 Controlled synthesis of ziprasidone |
| 04/18/2007 | EP1458386B1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder |
| 04/18/2007 | EP1394161B1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same |
| 04/18/2007 | EP1385526B1 3, 7 thia prostanoic acid derivatives as agents for lowering intraocular pressure |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1227812B1 Topical nasal treatment using desloratadine and mometasone furoate |
| 04/18/2007 | EP1153125B1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use |
| 04/18/2007 | EP1137408B1 Agent for lowering endothelin levels |
| 04/18/2007 | EP1037622B1 Taurine derivatives usable in the treatment of retinal disorders |
| 04/18/2007 | EP1007080B1 Formulation for the sustained release of peptide agonists and analogues of GnRH |
| 04/18/2007 | EP0960117B1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 04/18/2007 | EP0765169B1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 04/18/2007 | CN1950389A Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 04/18/2007 | CN1950372A 咪唑并吡啶化合物 Imidazopyridine compound |
| 04/18/2007 | CN1950091A Biodegradable intraocular implants containing prostamides |
| 04/18/2007 | CN1950067A Intraocular implants of alpha-2 adrenergic receptor agonists and methods for improving vision |
| 04/18/2007 | CN1947792A Method for preparing active protein composition type nano-selenium and its liquid phase storage tech. |
| 04/18/2007 | CN1947753A Therapy method specially for treating eye diseases |
| 04/18/2007 | CN1947687A Salt solution with sterilization function |
| 04/18/2007 | CN1310919C 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/18/2007 | CN1310900C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 04/18/2007 | CN1310667C Nebula removing pills |
| 04/18/2007 | CN1310665C Medicine for treating deaf-mutism |
| 04/18/2007 | CN1310658C Chinese violet containing capsule and its preparing process |
| 04/18/2007 | CN1310651C Pharmaceutical composition for use in ophthalmology and rhinology |
| 04/17/2007 | US7205435 Type B botulism toxin inhibitors |
| 04/17/2007 | US7205417 Spiro compounds |
| 04/17/2007 | US7205403 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 04/17/2007 | US7205392 Synergistic mixture of glycoprotein and angiogenesis inhibitor |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205151 Antiinflammatory agents; skin disorders |
| 04/17/2007 | US7205139 Expression vector comprising nucleotide sequences coding serine protease for use in diagnosis and treatment of thrombotic disorders |
| 04/17/2007 | CA2386799C Fused cycloheptane and fused azacycloheptane compounds and their as integrin receptor antagonists |
| 04/17/2007 | CA2348725C Vitamin d analogues |
| 04/17/2007 | CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
| 04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |